Advertisement

Picture EBD Group BioPharm America 2019 Boston September 600x60px
Organisation › Details

3B Pharmaceuticals GmbH (3BP)

3B Pharmaceuticals GmbH (3BP) is a German biotechnology company developing a pipeline of targeted radiopharmaceuticals to serve major unmet therapeutic and diagnostic needs of patients with cancer. All development candidates are exclusively derived from internal discovery efforts and aimed at theranostic combinations based on the same targeting molecule. As a leader in peptide discovery and optimization, 3B Pharmaceuticals GmbH (3BP) has built a technology platform extending from hit identification to early clinical development. Technologies are applied to both collaborative R&D and inhouse projects. 3BP was founded in 2008 by a team of renowned experts in peptide drug discovery and nuclear medicine from Berlin, Berne and Basel. Following a buyout of Jerini AG's R&D assets the company became operative in 2009 and is based in the southeast of Berlin. *

 

Period Start 2008-01-01 established
  Predecessor Jerini AG (FSE: JI4)
Products Industry peptide-based drug
  Industry 2 177Lu-IPN01087 (formerly 3BP-227)
Persons Person Reineke, Ulrich (3B Pharmaceuticals 201010 Managing Director)
  Person 2 Michel, Jan (3B Pharmaceuticals 201602 Director Finance + Corp Development)
     
Region Region Berlin
  Country Germany
  Street 11 Magnusstr.
  City 12489 Berlin
  Tel +49-30-6392-4317
    Address record changed: 2018-11-29
     
Basic data Employees B: 11 to 50 (2017-10-13)
     
    * Document for �About Section�: 3B Pharmaceuticals GmbH. (11/20/18). "Press Release: Ipsen and 3BP Announce First Patient Dosed in Phase I/II Study for First-in-class Radionuclide (IPN01087)". Paris.
     
   
Record changed: 2019-02-16

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

More documents for 3B Pharmaceuticals GmbH (3BP)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group BioPharm America 2019 Boston September 600x60px




» top